FindTrial
Sign In

Long-term follow-up of transvaginal natural orifice transluminal endoscopic surgery for sacrocolpopexy: machine learning helps to explore prognostic factors

Long-term follow-up of transvaginal natural orifice transluminal endoscopic surgery for sacrocolpopexy: machine learning helps to explore prognostic factors

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500105075
Enrollment
Unknown
Registered
2025-06-27
Start date
2025-06-30
Completion date
Unknown
Last updated
2025-06-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pelvic organ prolapse

Interventions

Single-port transvaginal laparoscopic sacrocolpopexy:NA

Sponsors

The Third Affiliated Hospital of Guangzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients who underwent vNOTES vaginal sacral colpopexy at the Third Affiliated Hospital of Guangzhou Medical University from June 2017 to August 2021 2. were followed up after the operation.

Exclusion criteria

Exclusion criteria: 1. History of autoimmune disease, connective tissue disease, or malignancy; 2. Patients who refused follow-up;

Design outcomes

Primary

MeasureTime frame
Postoperative lower urinary tract symptoms;Postoperative recurrence;—

Secondary

MeasureTime frame
Mesh exposed;Reoperation;Objective satisfaction;—

Countries

China

Contacts

Public ContactShuozhen

The Third Affiliated Hospital of Guangzhou Medical University

201968305@gzhmu.edu.cn+86 20 81292860

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026